Should I hold or sell F5 FFIV stock today F5 Posts 195 Percent EPS Beat Tops Street Views US February PPI and Residential Construction Input Cost Trends Analysis NRXP NRX Pharmaceuticals shares climb 352 percent as investors shrug off worse than expected Q4 2025 EPS miss Centene Corporation CNC Valuation Assessment Following Recent ShortTerm Share Price Rebound COEP Coeptis posts narrower Q3 2024 loss than analyst estimates shares rise slightly on upbeat investor sentiment